{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:53:13Z","timestamp":1795027993650,"version":"4.10.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Innovation Research and Practice Program of Anhui Medical University","award":["(YJS20240116)"],"award-info":[{"award-number":["(YJS20240116)"]}]},{"name":"Anhui Provincial Key Research and Development Program Fund","award":["(2022e07020065)"],"award-info":[{"award-number":["(2022e07020065)"]}]},{"name":"Ma'anshan Science and Technology Plan Project","award":["(YL-2024-02)"],"award-info":[{"award-number":["(YL-2024-02)"]}]},{"name":"Ma'anshan Science and Technology Innovation Breakthrough Plan Project","award":["(2024RGZN001)"],"award-info":[{"award-number":["(2024RGZN001)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15300-8","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:06:30Z","timestamp":1763701590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Quantification of intratumoral heterogeneity using habitat-based MRI radiomics for predicting high-Gleason scores and castration-resistant PCa: retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Cheng-Feng","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"1","key":"15300_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. CA Cancer J Clin 2024 Jan-Feb. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin 2024 Jan-Feb"},{"issue":"3","key":"15300_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","volume":"22","author":"EM Schaeffer","year":"2024","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al. NCCN Guidelines\u00ae insights: prostate Cancer, version 3.2024. J Natl Compr Canc Netw. 2024;22(3):140\u201350.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"15300_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/pin.12398","volume":"66","author":"RB Shah","year":"2016","unstructured":"Shah RB, Zhou M. Recent advances in prostate cancer pathology: Gleason grading and beyond. Pathol Int. 2016;66(5):260\u201372.","journal-title":"Pathol Int"},{"issue":"5","key":"15300_CR4","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.juro.2012.07.055","volume":"188","author":"HJ Lavery","year":"2012","unstructured":"Lavery HJ, Droller MJ. Do Gleason patterns 3 and 4 prostate cancer represent separate disease states? J Urol. 2012;188(5):1667\u201375.","journal-title":"J Urol"},{"issue":"3","key":"15300_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-016-0576-4","volume":"17","author":"A Matoso","year":"2016","unstructured":"Matoso A, Epstein JI. Grading of prostate cancer: past, present, and future. Curr Urol Rep. 2016;17(3):25.","journal-title":"Curr Urol Rep"},{"issue":"3","key":"15300_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD, et al. A contemporary prostate cancer grading system: A validated alternative to the Gleason score. Eur Urol. 2016;69(3):428\u201335.","journal-title":"Eur Urol"},{"issue":"2","key":"15300_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86(2):164\u201382.","journal-title":"Eur Urol"},{"key":"15300_CR8","doi-asserted-by":"crossref","unstructured":"Wilkinson S, Harmon SA, Terrigino NT, et al. A case report of multiple primary prostate tumors with differential drug sensitivity. Nat Commun. 2020;11(1):837.","DOI":"10.1038\/s41467-020-14657-7"},{"issue":"4","key":"15300_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.semnuclmed.2019.02.007","volume":"49","author":"S Woo","year":"2019","unstructured":"Woo S, Ghafoor S, Vargas HA. Contribution of radiology to staging of prostate cancer. Semin Nucl Med. 2019;49(4):294\u2013301.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"15300_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1148\/radiol.15141412","volume":"276","author":"L Kayat Bittencourt","year":"2015","unstructured":"Kayat Bittencourt L, Litjens G, Hulsbergen-van de Kaa CA, et al. Prostate cancer: the European society of urogenital radiology prostate imaging reporting and data system criteria for predicting extraprostatic extension by using 3-T multiparametric MR imaging. Radiology. 2015;276(2):479\u201389.","journal-title":"Radiology"},{"key":"15300_CR11","doi-asserted-by":"crossref","unstructured":"Barentsz JO, Choyke PL, Cornud F, Reply to Erik Rud and Eduard Baco\u2019s Letter to the re: Re: Jeffrey, Weinreb C, Jelle O, Barentsz PL, Choyke et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016;69:16\u201340. Eur Urol. 2016;70(5):e137-e138.","DOI":"10.1016\/j.eururo.2016.04.016"},{"issue":"11","key":"15300_CR12","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1109\/TMI.2019.2901928","volume":"38","author":"R Cao","year":"2019","unstructured":"Cao R, Mohammadian Bajgiran A, Afshari Mirak S, et al. Joint prostate cancer detection and Gleason score prediction in BpMRI via FocalNet. IEEE Trans Med Imaging. 2019;38(11):2496\u2013506.","journal-title":"IEEE Trans Med Imaging"},{"issue":"4","key":"15300_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10334-022-01006-6","volume":"35","author":"MC Fernandes","year":"2022","unstructured":"Fernandes MC, Yildirim O, Woo S, et al. The role of MRI in prostate cancer: current and future directions. MAGMA. 2022;35(4):503\u201321.","journal-title":"MAGMA"},{"issue":"1","key":"15300_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.crad.2016.09.013","volume":"72","author":"E Sala","year":"2017","unstructured":"Sala E, Mema E, Himoto Y, et al. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging. Clin Radiol. 2017;72(1):3\u201310.","journal-title":"Clin Radiol"},{"issue":"1","key":"15300_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13058-024-01921-7","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen H, Liu Y, Zhao J, et al. Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: a multicenter study. Breast Cancer Res. 2024;26(1):160.","journal-title":"Breast Cancer Res"},{"key":"15300_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1037896","volume":"12","author":"M Waqar","year":"2022","unstructured":"Waqar M, Van Houdt PJ, Hessen E, et al. Visualising spatial heterogeneity in glioblastoma using imaging habitats. Front Oncol. 2022;12:1037896.","journal-title":"Front Oncol"},{"issue":"4","key":"15300_CR17","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.21037\/qims-24-1642","volume":"15","author":"X Yin","year":"2025","unstructured":"Yin X, Sha H, Cao X, et al. Tumor habitat-derived radiomics features in pretreatment CT scans for predicting concurrent chemoradiotherapy responses in nasopharyngeal carcinoma: a retrospective study. Quant Imaging Med Surg. 2025;15(4):2917\u201328.","journal-title":"Quant Imaging Med Surg"},{"key":"15300_CR18","doi-asserted-by":"crossref","unstructured":"Pianykh OSD. Imaging and Communications in Medicine (DICOM)[M].PubMed. 2012.","DOI":"10.1007\/978-3-642-10850-1"},{"key":"15300_CR19","doi-asserted-by":"crossref","unstructured":"Calinski T. Harabasz,et al. A Dendrite Method for Cluster Analysis. Comm in Stats Simulation & Comp; 1974.","DOI":"10.1080\/03610917408548446"},{"issue":"21","key":"15300_CR20","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJMV Griethuysen","year":"2017","unstructured":"Griethuysen JJMV, Fedorov A, Parmar C, et al. Computational radiomics system to Decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"15300_CR21","first-page":"267","volume":"73","author":"R Tibshirani","year":"2011","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J Royal Stat Society: Ser B (Statistical Methodology). 2011;73(3):267\u201388.","journal-title":"J Royal Stat Society: Ser B (Statistical Methodology)"},{"issue":"3","key":"15300_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/biomedicines10030689","volume":"10","author":"J Morote","year":"2022","unstructured":"Morote J, Aguilar A, Planas J, et al. Definition of castrate resistant prostate cancer: new insights. Biomedicines. 2022;10(3):689. Published 2022 Mar 17.","journal-title":"Biomedicines"},{"key":"15300_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393","volume":"338","author":"JAC Sterne","year":"2009","unstructured":"Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.","journal-title":"BMJ"},{"issue":"1","key":"15300_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00752-w","volume":"14","author":"C Zhou","year":"2023","unstructured":"Zhou C, Zhang YF, Guo S, et al. Multiparametric MRI radiomics in prostate cancer for predicting Ki-67 expression and Gleason score: a multicenter retrospective study. Discover Oncol. 2023;14(1):133.","journal-title":"Discover Oncol"},{"issue":"1","key":"15300_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13058-024-01938-y","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen H, Liu Y, Zhao J, et al. Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: a multicenter study. Breast Cancer Res. 2024;26(1):173.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"15300_CR26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232047","volume":"309","author":"X Zhang","year":"2023","unstructured":"Zhang X, Su GH, Chen Y, et al. Decoding intratumoral heterogeneity: clinical potential of habitat imaging based on radiomics. Radiology. 2023;309(3):e232047.","journal-title":"Radiology"},{"issue":"4","key":"15300_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.path.2022.07.008","volume":"15","author":"E Baraban","year":"2022","unstructured":"Baraban E, Epstein J. Prostate cancer: update on grading and reporting. Surg Pathol Clin. 2022;15(4):579\u201389. https:\/\/doi.org\/10.1016\/j.path.2022.07.008.","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"15300_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ajcp\/aqw212","volume":"147","author":"RT Vollmer","year":"2017","unstructured":"Vollmer RT, Gleason, Grading. Biochemical Failure, and prostate Cancer-Specific death. Am J Clin Pathol. 2017;147(3):273\u20137.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"15300_CR29","first-page":"e319","volume":"23","author":"AU Kishan","year":"2022","unstructured":"Kishan AU, Sun Y, Hartman H, et al. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol. 2022;23(7):e319.","journal-title":"Lancet Oncol"},{"key":"15300_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2021.10.012","volume":"524","author":"TDNJ Flores-T\u00e9llez","year":"2022","unstructured":"Flores-T\u00e9llez TDNJ, Baena E. Experimental challenges to modeling prostate cancer heterogeneity. Cancer Lett. 2022;524:194\u2013205.","journal-title":"Cancer Lett"},{"issue":"40","key":"15300_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf0837","volume":"9","author":"GH Su","year":"2023","unstructured":"Su GH, Xiao Y, You C, et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci Adv. 2023;9(40):eadf0837.","journal-title":"Sci Adv"},{"issue":"6","key":"15300_CR32","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.acra.2023.11.024","volume":"31","author":"HF Liu","year":"2024","unstructured":"Liu HF, Wang M, Lu YJ, et al. CEMRI-Based quantification of intratumoral heterogeneity for predicting aggressive characteristics of hepatocellular carcinoma using habitat analysis: comparison and combination of deep learning. Acad Radiol. 2024;31(6):2346\u201355.","journal-title":"Acad Radiol"},{"issue":"5","key":"15300_CR33","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4103\/jcrt.jcrt_1719_21","volume":"19","author":"E Rani","year":"2023","unstructured":"Rani E, Nibhoria S, Nagpal N. Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: a study in a tertiary care hospital. J Cancer Res Ther. 2023;19(5):1305\u201310.","journal-title":"J Cancer Res Ther"},{"issue":"11","key":"15300_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","volume":"371","author":"ES Antonarakis","year":"2014","unstructured":"Antonarakis ES, Lu C, Wang H, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014;371(11):1028\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"15300_CR35","doi-asserted-by":"publisher","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z, et al. MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology. 2023;308(1):e222830.","journal-title":"Radiology"},{"issue":"1","key":"15300_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1148\/radiol.2018172462","volume":"288","author":"J Wu","year":"2018","unstructured":"Wu J, Cao G, Sun X, et al. Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy. Radiology. 2018;288(1):26\u201335.","journal-title":"Radiology"},{"issue":"6","key":"15300_CR37","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/jmri.26178","volume":"48","author":"R Shiradkar","year":"2018","unstructured":"Shiradkar R, Ghose S, Jambor I, et al. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: preliminary findings. J Magn Reson Imaging. 2018;48(6):1626\u201336.","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"15300_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.21037\/tcr.2016.06.20","volume":"5","author":"R Stoyanova","year":"2016","unstructured":"Stoyanova R, Takhar M, Tschudi Y, et al. Prostate cancer radiomics and the promise of radiogenomics. Transl Cancer Res. 2016;5(4):432\u201347.","journal-title":"Transl Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15300-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:46:40Z","timestamp":1767066400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15300"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15300-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Ma\u2019anshan People Hospital [(2024) No. 11 (02)], and informed consent was waived, given the retrospective study and anonymised data of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.(This manuscript does not contain any individual person\u2019s data in any form.)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1927"}}